TransMedics (TMDX) Shares Outstanding (2018 - 2026)

TransMedics has reported Shares Outstanding (Entity) for 9 years, with the latest figure at $34.6 million in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 1.73% year-over-year to $34.6 million in Q2 2026; TTM through Jun 2026 was $34.6 million, a 1.73% increase from a year earlier, with the FY2025 full-year figure at $34.3 million, up 1.93% from the prior year.
• Shares Outstanding (Entity) was $34.6 million for Q2 2026 at TransMedics, roughly flat from $34.5 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $34.6 million in Q2 2026, with the low at $28.0 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $32.7 million, with a median of $33.1 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) rose 16.32% in 2023, then climbed 0.98% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $32.1 million in 2022, then advanced by 1.65% to $32.7 million in 2023, then advanced by 2.9% to $33.6 million in 2024, then grew by 1.93% to $34.3 million in 2025, then climbed by 1.06% to $34.6 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $34.6 million (Q2 2026), $34.5 million (Q1 2026), and $34.3 million (Q4 2025), per Business Quant data.